BGM Leads for Blood Glucose Monitor Campaigns

Blood glucose monitors and test strips remain a staple of diabetes care, and Medicare covers them for beneficiaries who meet the criteria. AnJaanX generates qualified BGM leads, prospects screened for diabetes diagnosis, Medicare Part B coverage, and testing routine, so diabetic supply campaigns start from real eligibility instead of raw interest.

CGM gets the headlines, but traditional blood glucose monitoring still serves millions of patients, including many Medicare beneficiaries who test daily and are not on CGM. For DME suppliers, BGM is a steady, high-volume category with well-understood coverage rules and repeat supply orders. The catch is the same as in every DME category: unqualified volume burns money on shipping and documentation chases. Eligibility screening is what separates a profitable BGM program from an expensive one.

Medicare BGM Coverage Basics

Medicare Part B covers blood glucose monitors, test strips, and lancets for beneficiaries with diabetes who test their blood sugar. Coverage quantities depend on treatment: insulin-treated patients qualify for more frequent testing supplies than non-insulin-treated patients, and the treating physician must document the testing frequency in the medical record. A detailed written order is required before supplies ship, just as with other DME.

Our screening maps to these rules: diabetes diagnosis, insulin status, current testing frequency, active Part B coverage, and a physician who can document the order. Leads that do not fit the coverage profile are filtered out before delivery.

What a Qualified BGM Lead Includes

• Confirmed diabetes diagnosis: the medical basis for coverage is established up front.
• Insulin and testing profile: treatment type and testing routine that support the supply quantities being billed.
• Active Medicare Part B: coverage verified before the lead ships, not after the claim denies.
• Physician relationship: a treating doctor identified for the required documentation and order.
• Verified identity and consent: identity screening plus documented opt-in for contact about diabetic supplies.

BGM and CGM: Running Both Lines

BGM and CGM serve overlapping but distinct patient populations, and smart suppliers run both. Some beneficiaries qualify for and prefer CGM; others test with meters and need ongoing strip and lancet supplies. Our CGM lead generation and BGM programs share the same screening infrastructure, so a prospect who does not fit one program can often be routed to the other instead of being wasted. That routing discipline is one of the quiet advantages of running both lines with a single generation partner.

Campaign Structure and Terms

BGM campaigns run on clear commercial terms agreed up front: per-lead pricing for qualified, eligibility-checked prospects, defined delivery format and cadence, and replacement terms for leads that fail verification on delivery. Volume scales with your fulfillment capacity, because there is no point generating qualified demand faster than you can document and ship. We would rather pace generation to your operation than flood you with leads that age out.

Compliance for Diabetic Supply Marketing

The same rulebook applies here as across DME: FCC one-to-one consent for telemarketing contact, documented opt-ins naming the seller, CMS restrictions on beneficiary data sharing between marketing organizations, and marketing language that describes products factually without promising coverage or medical outcomes. Every BGM lead we deliver carries its consent record.

Fit With Your Existing Operation

BGM leads slot into the broader DME portfolio: our DME lead generation covers the wider equipment categories, and our medical billing outsourcing keeps claims and AR clean as supply volume grows. If you run a diabetic supply business, talk to us about which line, BGM, CGM, or both, fits your payer mix.

Frequently Asked Questions